Market Forecast By Product (Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Streptomycin, Kanamycin, Others), By Route of Administration (Injectables (Parenteral), Feed, Intra-mammary, Topical, Oral), By Application (Veterinary, Skin Infection, Respiratory diseases, UTI & Pelvic Diseases, Other diseases) And Competitive Landscape
Product Code: ETC312099 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The Saudi Arabia Aminoglycosides Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to 10.62% in 2027, following an initial rate of 8.44%, before easing to 9.16% at the end of the period.
The Saudi Arabia aminoglycosides market is part of the broader pharmaceutical industry. Aminoglycosides are antibiotics commonly used to treat bacterial infections. The market is driven by the demand for these antibiotics in healthcare settings and is influenced by factors such as disease prevalence and healthcare infrastructure development.
The saudi arabia aminoglycosides market is experiencing growth due to the rising incidence of bacterial infections and the need for effective antibiotics. Aminoglycosides are vital antibiotics used to treat severe bacterial infections, especially in healthcare settings. With the growing healthcare infrastructure and increasing awareness of healthcare-associated infections, the demand for aminoglycosides is on the rise. Additionally, the aging population and higher healthcare expenditure contribute to the market`s expansion.
The Saudi Arabia aminoglycosides market faces challenges related to antibiotic resistance and regulatory constraints. Aminoglycosides are crucial antibiotics used to treat various bacterial infections. However, the emergence of antibiotic-resistant bacteria poses a significant threat to their effectiveness. Strict regulatory oversight and the need for responsible antibiotic use can limit market growth. Additionally, the market may face competition from alternative antibiotics and the need for continuous research to develop new and more effective drugs.
The aminoglycosides market in Saudi Arabia experienced impacts from the COVID-19 pandemic. Aminoglycosides are important antibiotics used in healthcare settings. The pandemic strained healthcare systems and led to changes in medical practices, affecting the demand for antibiotics. Additionally, disruptions in pharmaceutical supply chains influenced the availability of aminoglycosides. While the market is expected to recover as healthcare systems stabilize, ongoing pandemic-related challenges could continue to shape the market`s evolution.
In the aminoglycosides market, key players include Hikma Pharmaceuticals, Jamjoom Pharma, and SPIMACO. These companies are pivotal in manufacturing aminoglycoside antibiotics used in the pharmaceutical industry.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Saudi Arabia Aminoglycosides Market Overview |
3.1 Saudi Arabia Country Macro Economic Indicators |
3.2 Saudi Arabia Aminoglycosides Market Revenues & Volume, 2021 & 2031F |
3.3 Saudi Arabia Aminoglycosides Market - Industry Life Cycle |
3.4 Saudi Arabia Aminoglycosides Market - Porter's Five Forces |
3.5 Saudi Arabia Aminoglycosides Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Saudi Arabia Aminoglycosides Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Saudi Arabia Aminoglycosides Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Saudi Arabia Aminoglycosides Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of bacterial infections in Saudi Arabia |
4.2.2 Growing awareness about the effectiveness of aminoglycosides in treating infections |
4.2.3 Rising investments in healthcare infrastructure and facilities in the country |
4.2.1 Antimicrobial resistance rate reduction (%) |
4.2.2 Increase in livestock population (million heads) |
4.2.3 Rise in hospital-acquired infection incidence (%) |
4.2.4 Healthcare spending per capita (USD) |
4.2.5 Increase in bacterial infection diagnosis rates (%) |
4.3 Market Restraints |
4.3.1 Stringent regulations and restrictions on the use of antibiotics |
4.3.2 Growing concerns about antibiotic resistance |
4.3.3 High cost associated with aminoglycosides treatment |
4.3.1 Regulatory restrictions on antibiotic use (% of regions affected) |
4.3.2 Nephrotoxicity incidence in patients (%) |
4.3.3 Market competition from other antibiotic classes (share %) |
4.3.4 Price volatility of raw material (USD/kg) |
4.3.5 Lack of awareness among rural population (%) |
4.4 Market KPI |
4.4.1 Annual aminoglycoside prescriptions (units) |
4.4.2 Hospital procurement volume (tons) |
4.4.3 Veterinary use penetration rate (%) |
4.4.4 Generic drug share in total sales (%) |
4.4.5 Average treatment duration (days) |
5 Saudi Arabia Aminoglycosides Market Trends |
6 Saudi Arabia Aminoglycosides Market, By Types |
6.1 Saudi Arabia Aminoglycosides Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Product, 2021-2031F |
6.1.3 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Neomycin, 2021-2031F |
6.1.4 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Tobramycin, 2021-2031F |
6.1.5 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Gentamicin, 2021-2031F |
6.1.6 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Amikacin, 2021-2031F |
6.1.7 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Paromomycin, 2021-2031F |
6.1.8 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Streptomycin, 2021-2031F |
6.1.9 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.1.10 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Others, 2021-2031F |
6.2 Saudi Arabia Aminoglycosides Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Injectables (Parenteral), 2021-2031F |
6.2.3 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Feed, 2021-2031F |
6.2.4 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Intra-mammary, 2021-2031F |
6.2.5 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Topical, 2021-2031F |
6.2.6 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Oral, 2021-2031F |
6.3 Saudi Arabia Aminoglycosides Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Veterinary, 2021-2031F |
6.3.3 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Skin Infection, 2021-2031F |
6.3.4 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Respiratory diseases, 2021-2031F |
6.3.5 Saudi Arabia Aminoglycosides Market Revenues & Volume, By UTI & Pelvic Diseases, 2021-2031F |
6.3.6 Saudi Arabia Aminoglycosides Market Revenues & Volume, By Other diseases, 2021-2031F |
7 Saudi Arabia Aminoglycosides Market Import-Export Trade Statistics |
7.1 Saudi Arabia Aminoglycosides Market Export to Major Countries |
7.2 Saudi Arabia Aminoglycosides Market Imports from Major Countries |
8 Saudi Arabia Aminoglycosides Market Key Performance Indicators |
8.1 Rate of adoption of aminoglycosides in Saudi Arabian hospitals |
8.2 Number of research studies highlighting the efficacy of aminoglycosides in the region |
8.3 Percentage of healthcare professionals recommending aminoglycosides as a treatment option |
9 Saudi Arabia Aminoglycosides Market - Opportunity Assessment |
9.1 Saudi Arabia Aminoglycosides Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Saudi Arabia Aminoglycosides Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Saudi Arabia Aminoglycosides Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Saudi Arabia Aminoglycosides Market - Competitive Landscape |
10.1 Saudi Arabia Aminoglycosides Market Revenue Share, By Companies, 2024 |
10.2 Saudi Arabia Aminoglycosides Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |